Alterations of the Wnt/β-catenin pathway and its target genes for the N- and C-terminal domains of parathyroid hormone-related protein in bone from diabetic mice

被引:62
作者
Portal-Nunez, S. [1 ]
Lozano, D. [1 ]
Fernandez de Castro, L. [1 ]
de Gortazar, A. R. [2 ]
Nogues, X. [3 ]
Esbrit, P. [1 ]
机构
[1] Fdn Jimenez Diaz, Capio Grp, Lab Metab Mineral & Oseo, E-28040 Madrid, Spain
[2] Univ San Pablo, CEU, Fac Med, Boadilla Del Monte 28668, Comunidad Madri, Spain
[3] Parc Salud Mar Parc Recerca Biomed Barcelona PRBB, Unitat Recerca Fisiopatol Osea & Articular, Barcelona 08003, Spain
关键词
Type 1 diabetes mellitus; Bone formation; PTHrP; Wnt/beta-catenin pathway; BETA-CATENIN; OSTEOPOROSIS; EXPRESSION; DIFFERENTIATION; OSTEOBLAST; FRAGMENTS; PROMOTES; MELLITUS; CELLS; MASS;
D O I
10.1016/j.febslet.2010.05.047
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Type 1 diabetes mellitus (T1D) is associated with bone loss. Given that the Wnt/beta-catenin pathway is a major regulator of bone accrual, we assessed this pathway in mice with streptozotozin-induced T1D. In diabetic mouse long bones, we found alterations favouring the suppression of this pathway by using PCR arrays and beta-catenin immunostaining. Downregulation of sclerostin, an inhibitor of this pathway, also occurred, and related to increased osteocyte apoptosis. Our data show that both N- and C-terminal parathyroid hormone-related peptide fragments might exert osteogenic effects in this setting by targeting several genes of this pathway and increasing beta-catenin in osteoblastic cells. (C) 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:3095 / 3100
页数:6
相关论文
共 29 条
[1]   NMDA-receptor activation induces calpain-mediated β-catenin cleavages for triggering gene expression [J].
Abe, Kentaro ;
Takeichi, Masatoshi .
NEURON, 2007, 53 (03) :387-397
[2]  
Baron Roland, 2007, Curr Osteoporos Rep, V5, P73
[3]   Regulation of osteoblastogenesis and bone mass by Wnt10b [J].
Bennett, CN ;
Longo, KA ;
Wright, WS ;
Suva, LJ ;
Lane, TF ;
Hankenson, KD ;
MacDougald, OA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (09) :3324-3329
[4]   Parathyroid hormone-related protein: An essential physiological regulator of adult bone mass [J].
Bisello, A ;
Horwitz, MJ ;
Stewart, AF .
ENDOCRINOLOGY, 2004, 145 (08) :3551-3553
[5]   Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non-osmotic pathways [J].
Botolin, Sergiu ;
McCabe, Laura R. .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2006, 99 (02) :411-424
[6]   Wnt inhibitory factor (WIF)-1 inhibits osteoblastic differentiation in mouse embryonic mesenchymal cells [J].
Cho, Sun Wook ;
Yang, Jae-Yeon ;
Sun, Hyun Jin ;
Jung, Ju Yeon ;
Her, Sun Ju ;
Cho, Hwa Young ;
Choi, Hyung Jin ;
Kim, Sang Wan ;
Kim, Seong Yeon ;
Shin, Chan Soo .
BONE, 2009, 44 (06) :1069-1077
[7]   Parathyroid hormone-related protein-(107-139) inhibits bone resorption in vivo [J].
Cornish, J ;
Callon, KE ;
Nicholson, GC ;
Reid, IR .
ENDOCRINOLOGY, 1997, 138 (03) :1299-1304
[8]   Transient exposure to PTHrP (107-139) exerts anabolic effects through vascular endothelial growth factor receptor 2 in human osteoblastic cells in vitro [J].
de Gortazar, A. R. ;
Alonso, V. ;
Alvarez-Arroyo, M. V. ;
Esbrit, P. .
CALCIFIED TISSUE INTERNATIONAL, 2006, 79 (05) :360-369
[9]   Mechanisms of bone repair and regeneration [J].
Deschaseaux, Frederic ;
Sensebe, Luc ;
Heymann, Dominique .
TRENDS IN MOLECULAR MEDICINE, 2009, 15 (09) :417-429
[10]  
de Castro LF, 2010, TISSUE ENG PT A, V16, P1157, DOI [10.1089/ten.tea.2009.0355, 10.1089/ten.TEA.2009.0355]